Breast Disorders: Fibrocystic Breast Changes, Breast Cancer
Breast Disorders: Fibrocystic Breast Changes, Breast Cancer ( 15 Questions)
A nurse is assessing a patient with fibrocystic breast changes.
Which clinical findings are consistent with this condition? Select all that apply.
Single palpable lump in the breast is consistent with fibrocystic breast changes. Fibrocystic breast changes can lead to the formation of cysts or lumps in the breast tissue, and a single palpable lump can be one of the clinical findings associated with this condition.
Hormonal fluctuations leading to tissue changes are consistent with fibrocystic breast changes. Hormonal fluctuations can cause breast tissue to become more nodular and lumpy, which is characteristic of fibrocystic breast changes.
Multiple palpable masses or lumps in the breasts are also consistent with fibrocystic breast changes. This condition can lead to the development of multiple cysts or lumps in the breast tissue, and this clinical finding aligns with the characteristics of fibrocystic breast changes.
Genetic mutations BRCA1 and BRCA2 are not consistent with fibrocystic breast changes. These genetic mutations are associated with an increased risk of breast cancer, not fibrocystic breast changes. Fibrocystic breast changes are primarily related to hormonal factors and tissue changes.
History of breast trauma or surgery is consistent with fibrocystic breast changes. Trauma to the breast or previous breast surgeries can contribute to the development of fibrocystic changes in breast tissue. These changes may manifest as lumps or discomfort in the breast.
Choice A rationale:
Single palpable lump in the breast is consistent with fibrocystic breast changes.
Fibrocystic breast changes can lead to the formation of cysts or lumps in the breast tissue, and a single palpable lump can be one of the clinical findings associated with this condition.
Choice B rationale:
Hormonal fluctuations leading to tissue changes are consistent with fibrocystic breast changes.
Hormonal fluctuations can cause breast tissue to become more nodular and lumpy, which is characteristic of fibrocystic breast changes.
Choice C rationale:
Multiple palpable masses or lumps in the breasts are also consistent with fibrocystic breast changes.
This condition can lead to the development of multiple cysts or lumps in the breast tissue, and this clinical finding aligns with the characteristics of fibrocystic breast changes.
Choice D rationale:
Genetic mutations BRCA1 and BRCA2 are not consistent with fibrocystic breast changes.
These genetic mutations are associated with an increased risk of breast cancer, not fibrocystic breast changes.
Fibrocystic breast changes are primarily related to hormonal factors and tissue changes.
Choice E rationale:
History of breast trauma or surgery is consistent with fibrocystic breast changes.
Trauma to the breast or previous breast surgeries can contribute to the development of fibrocystic changes in breast tissue.
These changes may manifest as lumps or discomfort in the breast.